BNP Paribas Asset Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
ACM
BNP Paribas Asset Management's CDLX Position: Q4 2021 in Review
BNP Paribas Asset Management sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 42,375 shares — an estimated $35.6M sold.
BNP Paribas Asset Management first reported a position in CDLX in Q2 2021 and held it in 2 quarters. The position peaked at $42.9M in Q2 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.
- BNP Paribas Asset Management reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
- BNP Paribas Asset Management sold 42,375 Cardlytics shares in Q4 2021, an estimated $35.6M.
- BNP Paribas Asset Management first reported a position in Cardlytics in Q2 2021 and held it in 2 quarters.
- BNP Paribas Asset Management's Cardlytics position peaked at $42.9M in Q2 2021.
- 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.
Based on BNP Paribas Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.